Download Professional Service

S. David Hudnall, M.D.
CURRICULUM VITAE
Stanley David Hudnall, M.D.
9 Edgehill Drive
Woodbridge, CT 06525
Professor of Pathology & Laboratory Medicine
Director, Hematopathology Service
Co-Director, Hematopathology Fellowship Program
Yale-New Haven Hospital
Education
July 1969 – June 1973
University of South Carolina
Columbia, SC
Bachelor of Science, Biology
July 1974 – June 1978
Medical University of South Carolina
Charleston, SC
Doctor of Medicine
July 1978 – June 1980
Yale University School of Medicine
New Haven, CT
Resident in Anatomic Pathology
July 1980 – June 1982
Yale University School of Medicine
New Haven, CT
Resident in Clinical Pathology
July 1982 – June 1984
Harvard Medical School
Boston, MA
Research Fellow in Pathology
Academic Appointments
July 1984 – June 1992
Assistant Professor
Attending in Hematopathology, UCLA Medical Center
Department of Pathology & Laboratory Medicine
UCLA School of Medicine
Los Angeles, CA
July 1992 – June 1994
Associate Professor
Attending in Hematopathology, The Methodist Hospital
Department of Pathology & Laboratory Medicine
Baylor College of Medicine
Houston, TX
July 1994 – June 2005
Associate Professor
1
S. David Hudnall, M.D.
Director of Hematopathology
Attending in Hematopathology, John Sealy Hospital
Department of Pathology & Laboratory Medicine
University of Texas Medical Branch
Galveston, TX
July 2005 – June 2009
Professor
Director of Hematopathology
Attending in Hematopathology, John Sealy Hospital
Department of Pathology & Laboratory Medicine
University of Texas Medical Branch
Galveston, TX
July 2009 – present
Professor
Director of Hematopathology
Attending in Hematopathology, Yale-New Haven Hospital
Co-Director, Hematopathology Fellowship Program
Member, Yale Comprehensive Cancer Center
Yale University School of Medicine
New Haven, CT
July 2011 – present
Associate Medical Director
Precipio Diagnostics
New Haven, CT
Yale Hematopathology Fellowship Trainees
2009-10
2010-11
2011-12
2012-13
2013-14
2014-15
2015-16
Tal Oren, M.D., Ph.D., Pathologist, Stamford Pathology Group, Stamford, CT
Bora Baysal, M.D., Ph.D., Associate Professor, Roswell Park Cancer Institute
Angie Duong, M.D., Assistant Professor, LSU Medical Center
Eric Scott. M.D., Pathologist, Commonwealth Laboratory Consultants, Richmond, VA
Alexa Siddon, M.D., Assistant Professor, VAMC, West Haven, CT
George Garib, M.D., Fellow, Bone and Soft Tissue Pathology, Univ of Pittsburgh
Lucy Kapur. M.D.
Brian Patonay, M.D.
Melissa Much, M.D.
Chris Nixon, M.D., Ph.D.
John Astle, M.D., Ph.D.
Sudhir Perincheri, M.D., Ph.D.
Administrative Positions
UTMB School of Medicine
2008-09
2007-08
2007
2007
Chair, Faculty Senate
Chair Elect, Faculty Senate
Presidential Search Committee for Associate Vice President and Chief Development
Officer
Vice-Chair, Faculty Quality Subcommittee, Faculty Senate
2
S. David Hudnall, M.D.
2006-09
2006-09
2006
2004-09
2004-09
2002-09
2001-03
2000-03
1999-09
1999-01
1997-01
1996-98
1996-98
1994-98
1995-96
Member, Faculty Senate
Academic Promotions and Tenure Committee (Pathology)
Liaison Committee on Medical Education (LCME) Self-Study Committee
Core Committee for Advancement of Women Faculty & Administrators
EMR Medical Management Model Committee
Co-Chair, IMC Course Directors Committee
Academic Promotions and Tenure Committee (Pathology)
Grading and Promotions Committee I
Chair, Dermatology-Hematology-Musculoskeletal Course Committee
Mission-Based Education Management Task Force
Faculty Coordinating Council
Primary Care Management Task Force
Academic Planning Committee, Experimental Pathology Program
Medical School Curriculum Committee
Faculty Compensation Plan Committee (Pathology)
Board Certification
1998
1997
1983
1979
American Board of Pathology, Hematology
American Board of Pathology, AP/CP voluntary recertification
American Board of Pathology, Anatomic and Clinical Pathology, RC-97-310
National Board of Medical Examiners
Medical Licensure
CT
NY
NJ
CA
TX
MO
PA
TN
48145
263585
25MA09044100
G55516
J2611
2012003991
MD444474
MD0000048361
Professional Honors & Recognition
A) International/National/Regional
20111990
1973
1969-73
Best Doctors in America
Faculty Member of Distinction, UCLA
Phi Beta Kappa, USC
Carolina Scholar, USC
B) University
2008-09
2007-08
2006-07
Best Lecturer, Clinical Pathology, UTMB
Best Lecturer, Clinical Pathology, UTMB
Best Lecturer, Clinical Pathology, UTMB
3
S. David Hudnall, M.D.
2005-06
2002-03
2001-02
2000-01
1999-00
1999-00
Best Lecturer, Clinical Pathology, UTMB
Best Lecturer, Clinical Pathology, UTMB
Best Lecturer, Clinical Pathology, UTMB
Best Lecturer, Clinical Pathology, UTMB
Best Lecturer, Clinical Pathology, UTMB
Best Faculty Award, Clinical Pathology, UTMB
Grant History
Current Grants:
Agency:
Title:
PI:
Total Costs:
Period:
Anna Fuller Fund
Whole Exome Sequencing of Hodgkin Lymphoma Cell Lines
Steven Kleinstein
$43,000
2011-12
Agency:
Title:
PI:
Total Costs:
Period:
George Dock Research Scholarship
Number and Distribution of Regulatory T/NK Cells in Human Lymphoma
Erin Barnhart & S. David Hudnall (faculty sponsor)
$4,000
2006-07
Agency:
Title:
Gulf Coast Regional Blood Center
Development of a Next Generation Real Time Multiplex PCR Assay for
Detection of Human Herpesviruses in Donor Blood
S. David Hudnall
$20,000
2005-06
PI:
Total Costs:
Period:
Agency:
Title:
PI:
Total Costs:
Period:
Gulf Coast Regional Blood Center, Houston, TX,
Prevalence of Herpesviremia in Healthy Adult Blood Donors by Pan-Herpes
Multiplex PCR
S. David Hudnall
$20,000
2003-04
Agency:
NIH
ID #:
R21 A154291-01
Title:
“Studies of the Pathogenic Mechanism of HIV”
PI:
Miles Cloyd
Total Costs: Unknown
Period:
2002-2004
Agency:
Title:
PI:
Total Costs:
3M Corp.
Immunohistochemical Analysis of Cellular Infiltrates Induced by Topical
Imiquimod
S. David Hudnall
$170,000
4
S. David Hudnall, M.D.
Period:
2000-01
Agency:
Title:
Gulf Coast Regional Blood Center
Further Characterization of Human Herpesvirus 8 Prevalence in Gulf Coast
Blood Donors: Ethnic Differences, HLA Associations, and Virus Strain Typing
S. David Hudnall
$30,000
1999-01
PI:
Total Costs:
Period:
Agency:
Title:
PI:
Total Costs:
Period:
Agency:
Title:
PI:
Total Costs:
Period:
Agency:
Title:
PI:
Total Costs:
Period:
Agency:
Title:
PI:
Total Costs:
Period:
Gulf Coast Regional Blood Center
Prevalence of Human Herpesvirus 8 Infection and Blood Infectivity in Normal
Adult Blood Donors and High Risk Groups in the Southeastern Texas Region
S. David Hudnall
$30,000
1997-99
Moran Foundation
Development of a Flow Cytometric Fluorescent In Situ Hybridization Technique
for Detection of Specific RNA in Phenotypically Defined Human Cell Lines
S. David Hudnall
$10,000
1993-94
Sandoz Pharmaceuticals
Identification of Factors Leading to Early Diagnosis of Post-Transplant
Lymphoproliferative Disease
S. David Hudnall
$20,000
1992-95
Ortho Pharmaceuticals
Identification of Factors Leading to Early Diagnosis of Post-Transplant
Lymphoproliferative Disease
S. David Hudnall, M.D.
$20,000
1992-95
Lectures, Courses, Web-based Education
2014
2013
2012
20112011
201020101999-09
1999-02
Invited speaker, Hodgkin Lymphoma and EBV-positive Lymphomas, New Delhi, India
Moderator, 8th International Conference on HHV-6 & HHV-7, Paris
Invited speaker, Viruses and Cancer, EBV, Mexican Society of Pathology, Mexico City
CME Section Director, Hematopathology, Opus Medicus
Moderator and Speaker, Viruses and Cancer. Binford-Dammin Society, USCAP
Meeting, San Antonio, TX
Lecturer, Pathology Resident Training Program, Yale University School of Medicine
Lecturer, Hematology Module, Yale University School of Medicine
Course Director, Dermatology, Hematology, & Musculoskeletal Systems, UTMB
Course Co-Director, Hematology & Immune Systems, UTMB Graduate School
5
S. David Hudnall, M.D.
1994-09
1994-96
1994-95
Lecturer, Graduate Student & Pathology Resident Training Programs, UTMB
Teaching Scientist, Boston Museum of Science Science-by-Mail Program
Teaching Scientist, Texas Math & Science Hotline, Texas Society for Biomedical
Research
Faculty Mentor, SMART Program, Baylor College of Medicine
Faculty Sponsor, UCLA Undergraduate Summer Research Program
Faculty Sponsor, UCLA Minority High School Summer Research Program
Lecturer in Hematopathology, Pathology Resident Training Program, UCLA
Laboratory Instructor, Clinical Pathology, Yale University
1992-94
1990-92
1990
1984-92
1981-82
Professional Service
Peer Review Groups/Grant Study Sections
2006-present
2000-present
2004-09
2002-05
Abstract Review Board, College of American Pathologists (CAP)
Abstract Review Board, U.S.-Canadian Academy of Pathology (USCAP)
George Dock Grant Selection Committee, UTMB
Hematology/Clinical Microscopy Resource Committee (CAP)
Journal Service
Editorial Boards:
2008200720052004-
Lymphoma
The Open Immunology Journal
Archives of Pathology and Laboratory Medicine
Transplantation
Reviewer:
2012
2007
2006
2006
2005
2004
2003
2000
1999
1997
Blood
Journal of Clinical Virology
Journal of Investigative Dermatology
Journal of Infection
Clinical Cytometry
European Journal of Clinical Microbiology & Infectious Diseases
Archives of Pathology & Laboratory Medicine
Clinical Infectious Disease
American Journal of Medical Science
U.S.-Canadian Academy of Pathology
Journal of Infectious Disease
Transplantation
Journal of the National Cancer Institute
American Journal of Clinical Pathology
American Journal of Pathology
Professional Organizations
Yale Comprehensive Cancer Center
6
S. David Hudnall, M.D.
International Association for Research on Epstein-Barr virus & Associated Diseases
Society for Hematopathology
Binford-Dammin Society for Infectious Disease Pathology
American Association for Cancer Research
International Society for Laboratory Hematology
American Society for Investigative Pathology
Clinical Cytometry Society
American Society of Clinical Pathologists
College of American Pathology
American Society of Hematology
U.S.-Canadian Academy of Pathology
American Society for Microbiology
Sealy Center for Cancer Cell Biology, UTMB
Sealy Center for Molecular Medicine , UTMB
Public Service
2013
1992-93
1989-92
Founder, Connecticut Hematopathology Society
Co-Director, Houston Citywide Hematopathology Conference, Houston, TX
Board of Trustees, Leukemia Society of America, Los Angeles Chapter
Bibliography
Peer-Reviewed Manuscripts
1. Hudnall SD. Experimental immunoproliferative disease: models for immune responses and
tumorigenesis. Survey of Immunological Research. 2:259-263, 1984.
2. Garcia CR, Brown NB, Schreck R, Stiehm FR, Hudnall SD. B cell the lymphoma is severe
combined immunodeficiency not associated with Epstein-Barr virus. Cancer 60:79, 1987.
3. Park NH, Hudnall SD, Paik DI, Stock AD. Establishment of two cell lines form hamster buccal
pouch tumors induced by topical 7,12-dimethylbenzanthracene and topical DMBA in
conjunction with herpes simplex virus infection. In Vitro Cell Develop Biol 24:1173-1178,
1988.
4. Hernandez-Jodra M, Hudnall SD, Petz LD. Studies of in vitro RBC autoantibody production in
normal subjects and in patients with autoimmune hemolytic anemia. Transfusion 30:411-417,
1990.
5. Hudnall SD. Cyclosporin A renders target cells resistant to immune cytolysis. Eur J Immunol
21:221-226, 1991.
6. Canfield CW, Hudnall SD, Colonna JO, Busuttil RW, Wilkinson AG, Danovitch G, Shekid A,
Goldstein L, Rosenthal JT. Fulminant EBV-associated post-transplant lymphoproliferative
disorders following OKT3 therapy. Clin Transpl 6:1-9, 1992.
7
S. David Hudnall, M.D.
7. Hudnall SD, Berenson JR. Clonal heavy chain isotype switching within the proliferation centers
of a small lymphocytic lymphoma: implications regarding the origin of proliferation centers.
Human Pathol 24:796-801, 1993.
8. Rubin D, Hudnall SD, Aisenberg A, Jacobson JO, Harris NL. Hodgkin’s-like transformation of
CLL: an unusual form of Richter's syndrome associated with EBV infection. Mod Path 7:91-98,
1994.
9. Chucrallah AE, M Crowe, Rice L, Rajagopalan S, Hudnall SD. Multiple myeloma following
cardiac transplantation: an unusual form of post-transplant lymphoproliferative disease. Human
Pathol 25:541-545, 1994.
10. Conway EJ, Hudnall SD, Lazarides A, Bahler A, Fraire AE Cagle PT. Absence of evidence for
etiologic role Epstein-Barr virus in 130 primary neoplasms of the lung and pleura. Mod Pathol
9:491-495, 1996.
11. Hudnall SD, Melez K, Galindo A, Bryson Y. Massive pseudolymphomatous pericardial effusion
in the post-transplant setting mimicking post-transplant lymphoproliferative disease.
Transplantation 61:1777-78, 1996.
12. Yen A, Fearneyhough P, Raimer S, Hudnall SD. EBV-associated Kikuchi’s histiocytic
necrotizing lymphadenitis with cutaneous manifestations. J Am Acad Dermatol 36:342-346,
1997.
13. Elghetany MT, Hudnall SD, Gardner FH. Peripheral blood picture in primary hypocellular
refractory anemia and idiopathic acquired aplastic anemia: an additional tool for different
diagnosis. Haematologica 82:21-24, 1997.
14. Stewart CC, Behm FG, Carey JL, Cornbleet J, Duque RE, Hudnall SD, Hurtubise PE, Loken M,
Tubbs RR, Wormsley S. U.S.-Canadian consensus recommendation on the immunophenotypic
analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations.
Cytometry 30:231-235, 1997.
15. Rady PL, Hodak E, Yen A, Memar O, Trattner A, Feinmesser M, David M, Hudnall SD, Tyring
SK. Detection of human herpesvirus-8 in Kaposi’s sarcomas from iatrogenically
immunosuppressed patients. J Am Acad Dermatol 38:429-37, 1998.
16. Haque AK, Myers JL, Hudnall SD, Gelman BB, Lloyd RB, Payne D, Borucki M. Pulmonary
lymphomatoid granulomatosis in AIDS: lesions with EBV infection. Mod Path 11:347-56, 1998.
17. Hudnall SD, Rady PL, Tyring SK, Fish JC. Serologic and molecular evidence of human
herpesvirus 8 activation in renal transplant recipients. J Infect Dis 178:1791-4, 1998.
18. Hudnall SD, Rady PL, Tyring SK, Fish JC. Hydrocortisone activation of human herpesvirus 8
viral DNA replication and gene expression in vitro. Transplantation 67: 648-52, 1999.
19. Walker DH, Hudnall SD, Szaniawski WK, Feng HM. Monoclonal antibody-based
immunohistochemical diagnosis of rickettsialpox: the macrophage is the principal target. Mod
Pathol 12:529-33, 1999.
8
S. David Hudnall, M.D.
20. Rady PL, Hudnall SD, Tyring S, Vargas T, Kellner LH, Nitowsky H, Matalon RK.
Methylenetetrahydrofolate reductase: the incidence of mutations C677T and A1298C in the
Ashkenazi population. Am J Med Genet 86:380-4, 1999.
21. Borkowski J, Amrikachi M, Hudnall SD. Fulminant Parvovirus infection following
erythropoietin treatment in a patient with acquired immunodeficiency syndrome. Arch Pathol
Lab Med 124: 441-445, 2000.
22. Yen-Moore A, Hudnall SD, Rady PL, Wagner RF, Moore TO, Memar O, Hughes TK, Tyring
SK. Differential expression of HHV-8 cellular homolog genes in HIV-positive and HIV-negative
Kaposi’s sarcoma: potential role for HIV-1 Tat. Virology 267: 247-251, 2000.
23. Hudnall SD, Molina CP. Marked increase in L-selectin-negative CD4-positive T cells in neonatal
pertussis: an explanation for the lymphocytosis? Am J Clin Pathol 114:35-40, 2000.
24. Hudnall SD. Kikuchi-Fujimoto disease. Is Epstein-Barr virus the culprit? Am J Clin Pathol 113:
761-764, 2000.
25. Stuart CA, Wen G, Peng B, Popov VL, Hudnall SD, Campbell GA: GLUT3 expression in human
skeletal muscle. Am J Physiol Endocrinol Metab 279:E855-E861, 2000.
26. Cao S, Hudnall SD, Kohen F, Lu LJ. Measurement of estrogen receptors in intact cells by flow
cytometry. Cytometry 41: 109-114, 2000.
27. Popnikolov NP, Payne D, Hudnall SD, Hawkins HK, Kumar MK, Norris BA, Elghetany MT.
CD13 Positive Anaplastic large cell lymphoma of T-cell origin: A diagnostic and histogenetic
problem. Arch Pathol Lab Med 124(12):1804-1808, 2000.
28. Kumar M, Boggino H, Hudnall SD, Velagaleti GVN. Acute myeloid leukemia associated with
hemophagocytic syndrome and t(4;7)(q21;q36). Cancer Genet Cytogenetics 122: 26-29, 2000.
29. Mathew P, Hudnall SD, Elghetany MT, Payne DA. T gamma gene rearrangement and CMV
mononucleosis. Am J Hematol 66:64-66, 2001.
30. Hudnall SD, Alperin JB, Petersen JR. Composite nodular lymphocyte predominance Hodgkin’s
disease and gamma heavy chain disease. Arch Path Lab Med 125: 803-807, 2001.
31. Rady PL, Szucs S, Matalon RK, Grady J, Hudnall SD, Kellner LH, Nitowsky H. Genetic
polymorphism of reduced folate carrier gene in ethnic populations. Molec Genet Metab 73:285286, 2001.
32. Walling DM, Flaitz CM, Nichols CM, Hudnall SD, Adler-Storthz K. Persistent productive EBV
replication in normal epithelial cells In vivo. J Infect Dis 184:1499, 2001.
33. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK.
Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine
synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR
polymorphic site. G1793A. Am J Med Genet 107: 162, 2002.
9
S. David Hudnall, M.D.
34. Martinez F, Filipowicz E, Hudnall SD. Plasma cell granuloma of the thyroid. Arch Pathol Lab
Med. 126:595-8, 2002.
35. Hudnall SD. Cardiac hypertrophy post-liver transplantation: a role for FK-506 and Cyclosporin
A? Transplantation 74:757-8, 2002.
36. Hudnall SD, Chen T, Rady PL, Tyring SK, Allison P. Human herpesvirus 8 seroprevalence and
viral load from healthy adult blood donors. Transfusion 43:85-90, 2003.
37. Hudnall SD, Patel J, Schwab H, Martinez, J. Comparative immunophenotypic features of EBVpositive and EBV-negative atypical lymphocytosis. Cytometry 55B(1):22-8, 2003.
38. Hudnall SD, Chen T, Brown K, Angel T, Schwartz, M, Tyring SK. Human herpesvirus 8
positive microvenular hemangioma in POEMS syndrome. Arch Pathol Lab Med 127:1034-36,
2003.
39. Hudnall SD, Chen T, Tyring SK. Species identification of all eight human herpesviruses with a
single nested PCR assay. J Virol Meth 116:19-26, 2004.
40. Ventura KC and Hudnall SD. Hematologic differences in heterophile-positive and heterophilenegative infectious mononucleosis. Am J Hematol 76:1-4, 2004.
41. Rady PL, Matalon R, Grady J, Smith EM, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK,
Hughes TK. Comprehensive analysis of genetic polymorphisms in the interleukin-10 promoter:
Implications for immune regulation in specific ethnic populations. Genetic Testing 8:194-203,
2004.
42. Zaharopoulos P, Hudnall SD. Nevus cell aggregates in lymph nodes: fine needle aspiration
cytologic findings and resulting diagnostic difficulties. Diagn Cytopathol 31: 180-184, 2004.
43. Hudnall SD. Crazy eight: unraveling herpesvirus-8 seroprevalence. Clin Infect Dis 39: 10591061, 2004.
44. Hudnall SD, Ge Y, Wei L, Yang, P, Wang H, Chen T. Distribution and phenotype of EpsteinBarr virus infected cells in human pharyngeal tonsils. Mod Path 18:519-27, 2005.
45. Koldzic-Zivanovic N, Tu H, Juelich T, Rady PL, Tyring SK, Hudnall SD, Smith EM, Hughes
TK. Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10
receptor in the adrenal zona fasciculata. Brain, Behavior, and Immunity 20: 460-468, 2006.
46. Chen T, Hudnall SD. Anatomic Mapping of Human Herpesvirus Reservoirs of Infection. Mod
Path 19: 726-737, 2006.
47. Hudnall SD, Northup J, Panova N, Suleman K, Velagaleti G. Prolonged Preleukemic Phase of
Chronic Myelogenous Leukemia. Exp Mol Pathol. 83:484-9, 2007.
10
S. David Hudnall, M.D.
48. Hudnall SD, Betancourt E, Barnhart E, Patel J. Comparative Flow Immunophenotype of
Hodgkin Lymphoma and Lymphoid Hyperplasia. Cytometry 74:1-8, 2008. (Best Original Paper
Award 2007-08)
49. Hudnall SD, Chen T, Amr S, Young K, Henry K. Detection of Human Herpesviruses in KikuchiFujimoto Lymphadenitis and Reactive Lymphoid Hyperplasia. Int J Clin Exp Pathol 1:362-368,
2008.
50. Millington K, Hudnall SD, Northup J, Panova N, Velagaleti G. Role of chromosome 1
pericentric heterochromatin (1q) in pathogenesis of myelodysplastic syndromes: Report of 2 new
cases. Exp Mol Pathol 84:189-93, 2008.
51. Singh A, Alperin JB, Gomez GA, Loop K, Hudnall SD, Cass AR, Raju GS. Mucosal associated
lymphoid tissue lymphoma of the colon presenting as autoimmune hemolytic anemia.
Gastrointest Endosc 67:1175-6, 2008.
52. Hudnall SD, Chen T, Allison P, Tyring S, Heath A. Herpesvirus Prevalence and Viral Load in
Healthy Adult Blood Donors by Quantitative Real Time PCR. Transfusion 48:1180-7, 2008.
53. Siddon A, Lozovatsky L, Mohamed A, Hudnall SD. Human herpesvirus 6 positive ReedSternberg cells in nodular sclerosis Hodgkin lymphoma. Br J Haematol 158:635-43, 2012.
Case Reports, Technical Notes, Letters
Letters to the Editor:
Hudnall SD, Berenson JR. Further evidence for in vivo isotype switching in B cell chronic
lymphocytic leukemia. Blood 87 (10), 4481, 1996.
Elghetany MT and Hudnall SD. Spurious automated white cell count with Coulter STKS® in the
myelodysplastic syndromes suggests the presence of a red cell membrane defect. Am J Hematol
52(1), 69, 1996.
Rady PL , Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Matalon RK. Genetic
Polymorphism of Reduced Folate Carrier Gene in Ethnic Populations. Mol Gen Metab 2001.
Reviews, Chapters, Books
Books:
Hematology: A Pathophysiologic Approach. S. David Hudnall (author). Mosby Physiology Series,
2012.
Viruses and Human Cancer. S. David Hudnall (editor in chief). Springer (in prep).
Atlas of Body Fluids, S. David Hudnall (section editor). College of American Pathologists,
Chicago, 2006.
Book Chapters:
11
S. David Hudnall, M.D.
Hudnall SD, Stanberry LR, Griffiths P: Chapter 57. Human Herpesvirus Infections, In: Guerrant
RL, Walker DH, Weller PF. Tropical Infectious Diseases: Principles, Pathogens, and Practice,
3rd edition. Elsevier Churchill, Livingstone. Philadelphia, (2011).
Hudnall SD, Yen-Moore A. Epstein-Barr virus. In: Tyring SK (ed.). Cutaneous Manifestations of
Viral Diseases, Marcel Dekker, New York, 2009.
Hudnall SD. Yen-Moore A. Human Herpesvirus 8. Tyring SK (ed.). Cutaneous Manifestations
of Viral Diseases, Marcel Dekker, New York, 2009.
Hudnall SD. Epstein-Barr Virus. In: Tyring SK (Ed.). Cutaneous Manifestations of Viral
Diseases, Marcel Dekker, New York, 2009.
Hudnall SD. Section Editor, Lymphoid Cells and Monocytes. Galagan K, et al. Atlas of Body
Fluids, College of American Pathologists, Chicago, 2006.
Hudnall SD, Stanberry LR: Chapter 57. Human Herpesvirus Infections, pp. 590-620. In:
Guerrant RL, Walker DH, Weller PF. Tropical Infectious Diseases: Principles, Pathogens, and
Practice, 2nd edition. Elsevier Churchill, Livingstone. Philadelphia, 2006.
O’Leary TJ, et al. Nucleic Acid Amplification Assays for Molecular Hematopathology;
Approved Guidlines, National Committee for Clinical Laboratory Standards, Wayne, PA, 2003.
Walling DM, Yen-Moore A, Hudnall SD. Epstein-Barr Virus. In: Tyring SK (Ed.). Cutaneous
Manifestations of Viral Diseases, Marcel Dekker, New York, 2001.
Hudnall SD. Human Herpesvirus Infections. In: Guerrant RL, Walker DH, Weller PF (Eds).
Essentials of Tropical Infectious Diseases. Churchill Livingstone, Philadelphia, 2001.
Hudnall SD. Human Herpesvirus Infections. In: Guerrant RL, Walker DH, Weller PF (Eds).
Tropical Infectious Diseases: Principles, Pathogens, and Practice, 1st edition. Elsevier
Churchill, Livingstone. Philadelphia, 1999.
Guidelines and Consensus Statements
National
Stewart CC, Behm FG, Carey JL, Cornbleet J, Duque RE, Hudnall SD, Hurtubise PE,
Loken M, Tubbs RR, Wormsley S. U.S.-Canadian consensus recommendation on the
immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of
antibody combinations. Cytometry 30:231-235, 1997.
Abstracts
1. Hudnall SD, Kurbe M. Cyclosporin A induced inhibition of EBV lymphoblastoid cell
regression: Reversal by rIL2. 6th Intl Congress of Immunology, July 1986.
12
S. David Hudnall, M.D.
2. Hudnall SD, Kurbe M. Role of antigen nonspecific effectors in the reversal of cyclosporin A
induced inhibition of EBV-B cell cytotoxicity by rIL2 and gamma interferon. 2nd International
EBV Conference, St. Petersburg Beach, FL, October 1986.
3. Hudnall SD, Kurbe M. Role of CD8+ and CD8- cytolytic effectors in IL2 reversal of
cyclosporin-inhibited EBV-B cell cytotoxicity. In: Epstein-Barr Virus and Human Disease (eds)
Levine PH, Ablashi DV, Pearson GR, Kottaridis SD. (Humana, New Jersey) 1987.
4. Park NH, Paik DI, Hudnall SD. Three cell lines derived from herpes simplex virus and 7,12dimethylbenzanthracene-induced tumors in hamster buccal pouches and skin. Intl Association of
Dental Research, 1988.
5. Hudnall SD, Glaspy J, Naeim F. Treatment of hairy cell leukemia with alpha and beta
interferon: Comparison of hematopathologic changes. US-Can Acad Path, Feb 1988.
6. Hernandez-Jodra M, Petz LD, Hudnall SD. RBC autoantibody production in lymphocyte
cultures. Intl Society for Blood Transfusion, London England, July 1988.
7. Hernandez-Jodra M, Petz LD, Hudnall SD. RBC autoantibody production in lymphocyte
cultures. American Society of Hematology, San Antonio TX, Dec 1988.
8. Hudnall SD, Blaesing LS, Koerner TAW. Transformation-induced glycosphingolipid expression
in human B lymphocytes. American Society of Biochemistry & Molecular Biology, San
Francisco CA, Jan 1989.
9. Hudnall SD, Berenson J. Evidence of a clonal isotype switch within the pseudofollicular
proliferation center of a small lymphocytic lymphoma: implications regarding the origin of
proliferation centers. US-Can Academy of Pathology, Boston MA, March 1990.
10. Yeghiayan P, Brownfield E, and Hudnall SD. Detection of EBV nucleic acid in human tissue by
a nonradioactive method. 4th National Conference for Undergraduate Research, Schenectady
NY, April 1990.
11. Hudnall SD, Zeidler M. Propagation and EBV infection of primary epithelial cells derived from
human tonsil and adenoid. 4th Intl EBV Conference, Taiwan, Sept 1990.
12. Hudnall SD, D Chou, Abbas A. Lymphokine reversal of the CSA mediate EBV LCL regression
defect: Implications for the pathogenesis of post-transplant LPD. American Society of
Hematology, Nov 1990.
13. Hudnall SD, Repinski C, Buckley C, Naeim F. Flow cytometric immunophenotypic of 50
normal human bone marrows: determination of 33 normal reference ranges. Clinical Cytometry
Society, Charleston SC, Sept 1991.
14. Hudnall SD, Cheng L, Susi E, Gordy W, Kobashigawa J. Anaplastic regressing EBV-positive
composite B/T cell post-transplant lymphoma. US-Can Academy of Pathology, Atlanta GA,
March 1992.
13
S. David Hudnall, M.D.
15. Chucrallah AE, M Crowe, Hudnall SD. Multiple myeloma following cardiac transplantation: an
unusual form of post-transplant lymphoproliferative disease. Texas Society of Pathologists,
Houston TX, Feb 1993.
16. Conway J, R Brown, SD Hudnall. Superiority of EBER1 In-situ hybridization to EBV LMP
immunostaining and EBNA1 PCR for detection of EBV from formalin-fixed paraffin-embedded
tissue. US-Can Acad Pathology, San Francisco CA, March 1994.
17. Hudnall SD, J Conway, JT Manning, BM Osborne. Multiparametric analysis of Epstein-Barr
virus in composite non-Hodgkins / Hodgkins lymphoma. US-Can Academy of Pathology, San
Francisco CA, March 1994.
18. Hudnall SD, M Grey, YD Li. Detection and immunophenotype of EBV infected cells by a rapid
two color immuno-in situ hybridization flow cytometric technique. 7th Intl EBV Conference,
Cold Spring Harbor NY, Sept 1994.
19. Imbing F, Haque AK, Gelman B, Hudnall SD. Pulmonary lymphoproliferative lesions in AIDS:
an association with EBV. US-Can Academy of Pathology, Toronto, March 1995.
20. Luthringer DJ, Yamashita J, Fishbein MC, Hudnall SD. Epicardial lymphoid infiltrates in cardiac
allografts are not Epstein-Barr virus associated. US-Can Academy of Pathology, Toronto, March
1995.
21. Hudnall SD, Conway J, Lazarides A, Bahler A, Li YD, Osborne B. Epstein Barr virus positive
Reed-Sternberg like cells in infectious mononucleosis associated lymphadenopathy. US-Can
Academy of Pathology, Toronto, March 1995.
22. Hudnall SD, Elghetany MT, Patel J. The flow immunophenotypic profile of atypical
lymphocytosis. Clinical Cytometry Society. Charleston SC, Sept 1995.
23. Hudnall SD, Sellers R, Yen A, Rady PL, Tyring SK. Detection of Kaposi’s sarcoma and posttransplant squamous lesions: Evidence for infection of both Kaposi’s sarcoma tissue and
squamous epithelium. US-Can Acad Pathol, Washington DC, March 1995.
24. Elghetany MT, Hudnall SD, Gardner FH. Aplastic anemia and primary hypoplastic refractory
anemia: Discrimination using peripheral blood morphologic findings prior to immunotherapy.
US-Can Academy of Pathology, Washington DC, March 1995.
25. Yen A, Rady PL, Hudnall SD, Sellers R, Wagner R, Orengo I, Bruce S, Tyring SK. Prevalence
of human herpesvirus 8 DNA in Kaposi’s sarcoma, carcinomas, and post-transplant squamous.
Society for Investigative Dermatology. 1995.
26. Yen A, Rady PL, Hudnall SD, Sellers R, Wagner R, Orengo I, Bruce S, Tyring SK. Prevalence
of HHV-S in cutaneous sarcomas and carcinomas. National Student Research Forum, Galveston
TX, 1995.
27. Wilcox GE, Hudnall SD, Gondo M, Stephenson M, Spjut H, Cagle PT. p53 expression in
papillary adenocarcinomas of the lung. US-Can Academy of Pathology, Washington DC, March
1995.
14
S. David Hudnall, M.D.
28. Rady P, Hudnall SD, Hodak E, Trattner A, Feinmesser M, David M, Sellers R, Yen A, Memar
O, Tyring SK. Presence of human herpesvirus 8 DNA in Kaposi’s sarcoma from patients treated
with corticosteroids. Intl AIDS Malignancy Conf, Bethesda MD, May 1996.
29. Rady PL, Hudnall SD, Hodak E, Trattner A, Feinmesser M, David M, Sellers R, Yen A, Memar
O, Tyring S. HHV-8 DNA in Kaposi’s sarcomas from patients treated with corticosteroids.
Institute for Human Virology, Baltimore MD, May 1996.
30. Rady PL, Hudnall SD, Hodak E, Trattner A, Feinmesser M, David M, Sellers R, Yen A, Memar
O, Tyring SK. Presence of HHV-8 in Kaposi’s sarcomas from iatrogenically immunosuppressed
patients. 1st Conf Intl Moritz Kaposi Research Foundation, Budapest, Hungary. Aug 1996.
31. Hudnall SD, Sellers R, Yen A, Orengo I, Bruce S, Rady PL, Tyring SK. In-situ detection of
Kaposi’s sarcoma associated herpesvirus (HHV-8) DNA in Kaposi’s sarcoma skin biopsies.
Institute for Human Virology, Baltimore MD, Sept 1996.
32. Vyas S, Youh G, Hudnall SD, Elghetany MT. p53 expression in marrow biopsies from patients
with hypercellular refractory anemia, hypocellular refractory anemia and aplastic anemia. Texas
Society of Pathologists, Corpus Christi, TX, Jan 1997.
33. Vyas S, Youh G, Hudnall SD, Elghetany MT. p53 expression in marrow biopsies from patients
with hypercellular refractory anemia, hypocellular refractory anemia and aplastic anemia. USCan Academy of Pathology, March 1997.
34. Rady P, Hodak E, Hudnall SD, Trattner A, Feinmesser M, David M, Gaspari A, Yen A, Memar
O, Tyring SK. Detection of HHV-8 DNA in Kaposi’s sarcomas from immunosuppressed
patients. Intl AIDS Malignancy Conf, Bethesda MD, 1997.
35. Hudnall SD, Rady P, Watson D, Orengo I, Bruce S, Tyring SK. Seroprevalence of human
herpes virus 8 in various Kaposi’s sarcoma risk groups in south Texas. Institute for Human
Virology, Baltimore MD, Sept 1997.
36. Rady P, Hudnall SD, Yen A, Hughes TK, Tyring SK. Frequency of human herpesvirus 8
cellular homolog gene expression in Kaposi’s sarcoma and BCBL-1 cells. Institute for Human
Virology, Baltimore MD, Sept 1997.
37. Rady PL, Yen A, Hudnall SD, Hughes TK, Tyring SK. Expression of human herpesvirus 8
cellular homolog genes in Kaposi’s sarcomas and BCBL-1 cell lines. American Academy of
Dermatology. Feb 1998.
38. Hudnall SD, Rady PL, Yen A, Tyring SK. Effect of hydrocortisone treatment on human
herpesvirus 8 viral DNA replication and gene expression in BCBL-1 cells. 1st Intl KSHV
Meeting, UC Santa Cruz, CA. July 1998.
39. Hudnall SD, Dang T, Rady P, Allison P. HHV-8 seroprevalence and viremic status of adult
blood donors and renal transplant patients from the southeast Texas region. 1st Intl KSHV
Meeting, UC Santa Cruz, CA. July 1998.
15
S. David Hudnall, M.D.
40. Hudnall SD, Rady PL, Yen A, Tyring SK. In-vitro steroid induced activation of HHV-8.
Institute for Human Virology, Baltimore MD, Aug 1998.
41. Hudnall SD, Rady PL, Tyring SK, Fish JC. Serologic and molecular evidence of human
herpesvirus 8 activation in renal transplant recipients. Infect Disease & Host Defense Poster
Session, UTMB, Nov 1998.
42. Hudnall SD. Flow Cytometry and In-Situ Hybridization Core Facility. Infectious Disease & Host
Defense Poster Session, UTMB, Nov 1998.
43. Matalon RK, Tyring SK, Rady P, Hudnall SD, Vargas T, Nitowsky H, Kellner LH.
Methylenetetrahydrofolate reductase: High incidence of mutation C677T in Ashkenazi Jewish
population. Society for Pediatric Research, 1999.
44. Hudnall SD, Rady PL, Allison P. HHV8 prevalence and genomic variation in adult blood donors
from the Texas Gulf coast region. Institute for Human Virology, Baltimore MD, 1999 (JAIDS
21(1): A18, 1999).
45. Ventura KG, Hudnall SD. Statistically significant hematologic abnormalities in heterophile
antibody positive and negative mono patients. CAP-ASCP Conf. New Orleans, LA. Nov 1999.
46. Cao S, Hudnall SD, Lu LJ. Downregulation of estrogen receptor by phytoestrogens daidzein and
genistein in MCF-7 breast cancer cells. AACR, 2000.
47. Hudnall SD, Chen T, Al-Salameh A. Human herpesvirus 8 in acute tonsillitis and tonsillar
hyperplasia. U.S.-Can. Academy of Pathology, New Orleans LA, March 2000.
48. Stuart CA, Wen G, Peng B, Popov VL, Hudnall SD, Campbell GA. Contributions from Ttubules and peripheral nerves to human muscle GLUT3. Am Diabetes Assoc, 2000.
49. Popnikolov NK, Payne DA, Hudnall SD, Hawkins HK, Kumar M, Elghetany MT. CD13
positive anaplastic large cell lymphoma of T-cell origin: A diagnostic and histogenetic problem.
Texas Society of Pathologists, Houston TX, Feb 2000.
50. Walling DM, Flaitz CM, Nichols CM, Hudnall SD. Non-lytic productive EBV replication in
normal tongue epithelial cells in vivo. 9th Intl EBV Assoc, New Haven CT, June 2000.
51. Hudnall SD, Chen T, Rady P, Tyring S, Allison P. HHV-8 seroprevalence and viral load in adult
blood donors from southeast Texas. 9th Intl EBV Assoc, New Haven, June 2000
52. Hudnall SD. The histopathology of EBV and HHV-8 associated diseases. 9th Intl EBV Assoc,
New Haven CT, June 2000.
53. Hudnall SD, Chen T, Rady P, Tyring S, Allison P. Low HHV-8 seroprevalence and absent
blood-borne virus in adult blood donors from the Texas Gulf Coast. 3rd International Workshop
on Kaposi’s Sarcoma Associated Herpesvirus, Amherst, MA, Jul 2000.
16
S. David Hudnall, M.D.
54. Rady PL, Tyring SK, Hudnall SD. Increased expression of human herpesvirus 8 vGCR in
AIDS-associated Kaposi’s Sarcoma. 2nd International Mortiz Kaposi Research Foundation Conf,
Budapest, Hungary, Aug 2000.
55. Hudnall SD, Chen T, Patel J, Martinez J, Schwab H. A detailed flow immunophenotype of
atypical lymphocytosis in infectious mononucleosis. USCAP Annual Meeting, Atlanta, GA,
March 2001.
56. Wang S, Hudnall SD. Differences in lymphocyte subsets in nodular sclerosis Hodgkin’s disease,
mixed cellularity Hodgkin’s disease, and reactive lymphoid hyperplasia: A flow cytometric
study. ASCP/CAP Fall Annual Meeting, Philadelphia, PA, October 2001.
57. Cinclair R, Daller JA, Rice J, Hudnall SD, Agraharkar M. Hypovolemic hyponatremia from
unusual neoplasia. Finalist, Clinical Vignette Competition, American College of Physicians –
American Society of Internal Medicine Annual Meeting, Philadelphia PA, April 13, 2002.
58. Wang L, Hudnall SD. CD8 T cell lymphocytosis and stem cell depletion in HIV-1 positive
marrow biopsies: correlation with anemia and thrombocytopenia. USCAP Annual Meeting,
Washington DC, Feb 2003.
59. Molina CP, Hudnall SD. Comparison of the inflammatory infiltrates of endemic African and
epidemic AIDS-associated Kaposi’s sarcoma. USCAP Annual Meeting, Washington DC, Feb
2003.
60. Gokhale S, Hudnall SD. Lack of correlation between CD38 expression and hematologic
parameters in chronic lymphocytic leukemia. Pan-Pacific Lymphoma Conference, Hawaii, July
2003.
61. Wang S, Hudnall SD. Immunophenotype of the reactive lymphoid infiltrate of Hodgkin’s
lymphoma: a flow cytometry study. Pan-Pacific Lymphoma Conference, Hawaii, July 2003.
62. Ge Y, Hudnall SD. Distribution of Epstein Barr virus in human tonsils. USCAP Annual
Meeting, Stowell-Orbison Competition, Vancouver, BC, March 2004.
63. Hudnall SD, Chen T. Complete Whole Body Mapping of Tissue Reservoirs of Human
Herpesvirus Infection with a Pan-Herpes PCR Technique. Platform presentation, USCAP Annual
Meeting, San Antonio, Feb 2005.
64. Hudnall SD, Chen T, Jackson S, Sanchez R. Detection of Human Herpesviruses in Pityriasis
Rosea Skin Biopsies. USCAP Annual Meeting, Atlanta, Feb 2006.
65. Hudnall SD, Chen T, Amr S, Henry K. Detection of Human Herpesviruses in Kikuchi-Fujimoto
Lymphadenitis. USCAP Annual Meeting, Atlanta, Feb 2006.
66. Velagaleti G, Northup J, Suleman K, Panova N, Hudnall SD. Detection of Philadelphia
chromosome (Ph) in a patient with no evidence of leukemia: Further evidence of a changing
paradigm? Am Soc Human Genetics, New Orleans, 2006.
17
S. David Hudnall, M.D.
67. Shuttlesworth J, Hudnall SD. Uninvolved Staging Bone Marrow Abnormalities in Classic
Hodgkin Lymphoma with Hematologic Correlation. Texas Society of Pathologists. January
2007.
68. Betancourt E, Patel J, Barnhart E, Hudnall SD. Comparative Flow Immunophenotype of
Hodgkin Lymphoma and Lymphoid Hyperplasia. Texas Society of Pathologists. January 2007.
3rd Prize.
69. Millington K, Hudnall SD, Northup J, Panova N, Velagaleti G. Role of chromosome 1
pericentric heterochromatin (1q12) in pathogenesis of myelodysplastic syndromes. Texas Society
of Pathologists. January 2007.
70. Wahbah M, Shuttlesworth J, Northup J, Panova N, Elghetany T, Hudnall SD, Velagaleti G. Twohit hypothesis revisited: origin of cytogenetically abnormal cells in histologically normal bone
marrows of cancer patients. Texas Society of Pathologists. January 2007.
71. Barnhart E, Hudnall SD. Regulatory and cytotoxic T cell subsets in Hodgkin lymphoma.
Stowell-Orbison Competition, USCAP, San Diego, March 2007.
72. Shuttlesworth J, Hudnall SD. Uninvolved staging bone marrow abnormalities in classic Hodgkin
Lymphoma with hematologic correlation. ASCP Annual Meeting. October 2007.
73. Perez M, Patel J, Hudnall SD. Immunophenotypic differences of tumor-infiltrating T cells in
subtypes of B cell lymphoma. USCAP. Denver, March 2008.
74. Hudnall SD, Crim J, Patel J, Giddings K, Martinez J. Abnormal immunophenotypic profile of
reactive T cells in chronic lymphocytic leukemia. Clinical Cytometry Society. Portland, October
2008.
75. Hudnall SD, Chen T, Barnhart E, Konig R. Inflammatory cytokine genes in Hodgkin lymphoma.
USCAP Platform Presentation, Boston, March 2009.
76. Siddon A, Lozavatsky L, Mohamed A, Hudnall SD. HHV-6 positive Reed-Sternberg cells in
nodular sclerosis Hodgkin lymphoma. USCAP, Vancouver, March 2012.
18